Physician profile
Fram Buhari
NPI 1811906894
$13,701.17
in general payments reported to CMS, 2019-2025
49 companies · $2,146 in 2025
The $2,146 reported for 2025 was more than what 84% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,918 · 2020: $187 · 2021: $1,204 · 2022: $3,160 · 2023: $1,651 · 2024: $2,436 · 2025: $2,146.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,902 · Travel and Lodging: $330.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,901.91 |
| Travel and Lodging | $330.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shockwave Medical, INC | $1,452.55 | 2019-2025 | |
| Medtronic Vascular, INC. | $883.35 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $870.54 | 2019-2025 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $829.94 | 2019-2025 | Farxiga |
| Janssen Pharmaceuticals, INC | $775.04 | 2019-2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $724.94 | 2019-2025 | |
| Pfizer INC. | $698.28 | 2019-2025 | |
| Abbott Laboratories | $670.97 | 2019-2024 | Gallant, Cardiomems |
| Medtronic, INC. | $630.05 | 2021-2023 | Reveal Linq |
| Merck Sharp & Dohme LLC | $619.00 | 2022-2025 | Verquvo |
| Impulse Dynamics (USA) INC. | $616.50 | 2022-2024 | Optimizer, Optimizer |
| Amgen INC. | $515.15 | 2019-2025 | Repatha, Repatha |
| Abiomed | $437.78 | 2019-2023 | Impella |
| Novo Nordisk INC | $398.15 | 2021-2025 | Wegovy, Rybelsus, Ozempic |
| Kiniksa Pharmaceuticals International, Plc | $382.94 | 2024 | Arcalyst |
Show all 49 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fram Buhari listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.